Huafon Chemical's board has approved acquiring 100% of Zhejiang Huafon Synthetic Resin, which makes polyurethane resins for synthetic leather, and 100% of Zhejiang Huafon Thermoplastic Polyurethane, whose TPU goes into footwear, electronics, sporting goods, automotive, tubing, cable and film. Total consideration is CNY 6.85 billion (reported by PU Magazine International as about USD 960 million), split CNY 4.15 billion for the resin business and CNY 2.70 billion for the TPU business. The sellers are the controlling shareholder Huafon Group, which held 51% of the resin company and all of the TPU company, together with members of the founding family, making this a related-party transaction. Board approval is not the last step: the deal still requires a shareholder vote at which related shareholders must abstain.
The consideration is mostly paper. Huafon Chemical would pay approximately CNY 1.02 billion in cash and issue around 690 million shares to cover the remaining CNY 5.83 billion. The transaction also has a history: an earlier CNY 6 billion version of the proposal was rejected by shareholders in April 2025 after failing to secure the required two-thirds majority, and the process restarted in June 2026 at a price approximately 14% higher than the one proposed in 2025.
This is Chinese polyurethane consolidation moving downstream rather than upstream. Nothing in the deal adds isocyanate or polyol capacity; it concentrates formulated PU products (synthetic-leather resin and TPU) inside the listed company, which gives those businesses a single balance sheet and easier access to capital for expansion.
There is a limit to what the figures support. The report gives no tonnage and no plant locations for either business, so the CNY 6.85 billion valuation says nothing directly about capacity. It is a price for two companies, not a measure of tonnes, and the roughly 14% uplift on the 2025 proposal reflects a renegotiated valuation rather than any disclosed change in output.
For a polyurethane systems producer, the relevance depends on which categories it sells into. The deal does not touch isocyanate supply or rigid-system economics, so no read-across to MDI availability or to cold-chain formulation costs is warranted. Where it does register is in the export markets where PU resin and TPU compete on price: a better-capitalised Chinese producer in those categories is a competitive fact to plan around over the next few years, not a supply event. And the shareholder vote is still outstanding, with related parties barred from voting, which is precisely the hurdle the 2025 attempt failed to clear.